BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31250339)

  • 1. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients.
    Siddiqui K; Joy SS; Al-Rubeaan K
    Int Urol Nephrol; 2019 Aug; 51(8):1379-1386. PubMed ID: 31250339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
    Nadkarni GN; Rao V; Ismail-Beigi F; Fonseca VA; Shah SV; Simonson MS; Cantley L; Devarajan P; Parikh CR; Coca SG
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1343-1352. PubMed ID: 27189318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
    BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T; Fujita H; Narita T; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
    J Diabetes Complications; 2003; 17(1):11-5. PubMed ID: 12505750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
    Banba N; Nakamura T; Matsumura M; Kuroda H; Hattori Y; Kasai K
    Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG; Sadik NA
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of kidney biomarkers [Kidney injury molecule-1, Calbindin, Interleukin-18 and Monocyte chemoattractant protein-1] in HIV associated pre-eclampsia.
    Eltounali SA; Moodley J; Naicker T
    Hypertens Pregnancy; 2017 Nov; 36(4):288-294. PubMed ID: 29039974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
    Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
    J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B; Tekce H; Aktas G; Sit M
    Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
    Tashiro K; Koyanagi I; Saitoh A; Shimizu A; Shike T; Ishiguro C; Koizumi M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
    J Clin Lab Anal; 2002; 16(1):1-4. PubMed ID: 11835523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
    Ibrahim S; Rashed L
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):911-7. PubMed ID: 18974575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.